Insmed (INSM) PT Lowered to $241 at TD Cowen as 'Ph2 Brenso BiRCh Misses'
Tweet Send to a Friend
TD Cowen analyst Ritu Baral lowered the price target on Insmed (NASDAQ: INSM) to $241.00 (from $269.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
